Most Recent
The law firm running a class action against Exactech over allegedly faulty joint implants is facing the "impossible task" of settling the case by January, the "drop dead" deadline for resolving the claim under its US parent company's restructuring.
Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
A commission baked into a funding agreement in a class action against Mayne Pharma is under threat, with a judge mulling an order off his own bat to cut the rate.
Australian Clinical Labs may seek to strike out part of the OAIC's case over a 2022 data breach, arguing it would unfairly allow the watchdog to allege both single and multiple contraventions of privacy law.
The competition regulator has given its blessing to the $8.8 billion merger of Chemist Warehouse and Sigma Healthcare, subject to a promise that franchisees will be free to terminate their contracts.
The ACCC has red flags about the acquisition of Japanese healthcare business I'rom Group by private equity behemoth Blackstone.
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
A class action over deaths allegedly caused by negligent care at a NSW aged care facility during COVID-19 has settled.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
A judge has ordered Victoria's Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.